Russell Investments Group, Ltd. Arcus Biosciences, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 10,410 shares of RCUS stock, worth $161,355. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,410

Previous 486 2041.98%

Holding current value

$161,355

Previous $7,000 2171.43%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$13.69 - $18.01 $135,859 - $178,731	9,924 Added 2041.98%	10,410 $159,000
Q2 2024 Aug 08, 2024	BUY	$14.59 - $18.48 $6,944 - $8,796	476 Added 4760.0%	486 $7,000
Q1 2024 May 08, 2024	SELL	$14.83 - $20.18 $235,277 - $320,155	-15,865 Reduced 99.94%	10 $0
Q4 2023 Feb 05, 2024	BUY	$13.43 - $19.63 $604 - $883	45 Added 0.28%	15,875 $303,000
Q3 2023 Nov 13, 2023	SELL	$17.62 - $23.54 $22,377 - $29,895	-1,270 Reduced 7.43%	15,830 $284,000
Q2 2023 Aug 10, 2023	SELL	$16.97 - $22.03 $188,451 - $244,643	-11,105 Reduced 39.37%	17,100 $347,000
Q1 2023 May 09, 2023	BUY	$15.96 - $23.15 $381,523 - $553,400	23,905 Added 555.93%	28,205 $514,000
Q4 2022 Feb 08, 2023	BUY	$19.7 - $35.71 $84,710 - $153,553	4,300 New	4,300 $88,000
Q3 2021 Nov 08, 2021	SELL	$26.93 - $37.68 $283,842 - $397,147	-10,540 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$22.75 - $35.77 $14,969 - $23,536	-658 Reduced 5.88%	10,540 $287,000
Q1 2021 May 10, 2021	BUY	$26.16 - $41.39 $292,939 - $463,485	11,198 New	11,198 $314,000
Q3 2020 Nov 09, 2020	SELL	$17.14 - $25.47 $138,834 - $206,307	-8,100 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$13.97 - $36.56 $174,625 - $457,000	-12,500 Reduced 60.68%	8,100 $200,000
Q4 2019 Jan 29, 2020	SELL	$7.33 - $10.79 $5,240 - $7,714	-715 Reduced 3.35%	20,600 $207,000
Q3 2019 Nov 01, 2019	BUY	$6.44 - $10.18 $33,990 - $53,730	5,278 Added 32.91%	21,315 $195,000
Q2 2019 Aug 09, 2019	BUY	$7.29 - $13.38 $116,909 - $214,575	16,037 New	16,037 $128,000

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.12B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Arcus Biosciences, Inc. Transaction History